Robinson D - Search Results

1

Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.

Diver S, Haldar K, McDowell PJ, Busby J, Mistry V, Micieli C, Brown V, Cox C, Yang F, Borg C, Shrimanker R, Ramsheh MY, Hardman T, Arron J, Bradding P, Cowan D, Mansur AH, Fowler SJ, Lordan J, Menzies-Gow A, Robinson D, Matthews J, Pavord ID, Chaudhuri R, Heaney LG, Barer MR, Brightling C; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium). Diver S, et al. Among authors: robinson d. Allergy. 2022 Nov;77(11):3362-3376. doi: 10.1111/all.15425. Epub 2022 Jul 15. Allergy. 2022. PMID: 35778780 Free article.

2

Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge.

Zeibecoglou K, Macfarlane AJ, Ying S, Meng Q, Pavord I, Barnes NC, Robinson DS, Kay AB. Zeibecoglou K, et al. Among authors: robinson ds. Allergy. 1999 Jul;54(7):730-5. doi: 10.1034/j.1398-9995.1999.00058.x. Allergy. 1999. PMID: 10442529

3

Eosinophil chemokines and their receptors: an attractive target in asthma?

Menzies-Gow A, Robinson DS. Menzies-Gow A, et al. Among authors: robinson ds. Lancet. 2000 May 20;355(9217):1741-3. doi: 10.1016/S0140-6736(00)02258-3. Lancet. 2000. PMID: 10832821 No abstract available.

4

Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma.

Menzies-Gow A, Robinson DS. Menzies-Gow A, et al. Curr Opin Pulm Med. 2002 Jan;8(1):33-8. doi: 10.1097/00063198-200201000-00006. Curr Opin Pulm Med. 2002. PMID: 11753121 Review.

5

Eosinophil chemokines and chemokine receptors: their role in eosinophil accumulation and activation in asthma and potential as therapeutic targets.

Menzies-Gow A, Robinson DS. Menzies-Gow A, et al. Among authors: robinson ds. J Asthma. 2001 Dec;38(8):605-13. doi: 10.1081/jas-100107538. J Asthma. 2001. PMID: 11758889 Review. No abstract available.

6

Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Flood-Page PT, et al. Am J Respir Crit Care Med. 2003 Jan 15;167(2):199-204. doi: 10.1164/rccm.200208-789OC. Epub 2002 Oct 17. Am J Respir Crit Care Med. 2003. PMID: 12406833 Clinical Trial.

7

Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics.

Menzies-Gow A, Flood-Page P, Sehmi R, Burman J, Hamid Q, Robinson DS, Kay AB, Denburg J. Menzies-Gow A, et al. J Allergy Clin Immunol. 2003 Apr;111(4):714-9. doi: 10.1067/mai.2003.1382. J Allergy Clin Immunol. 2003. PMID: 12704348 Clinical Trial.

8

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics.

Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, Barnes N, Robinson D, Kay AB. Flood-Page P, et al. Among authors: robinson d. J Clin Invest. 2003 Oct;112(7):1029-36. doi: 10.1172/JCI17974. J Clin Invest. 2003. PMID: 14523040 Free PMC article. Clinical Trial.

9

Severe asthma treatment: need for characterising patients.

Heaney LG, Robinson DS. Heaney LG, et al. Lancet. 2005 Mar 12-18;365(9463):974-6. doi: 10.1016/S0140-6736(05)71087-4. Lancet. 2005. PMID: 15767000 Review.

10

Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers.

Menzies-Gow AN, Flood-Page PT, Robinson DS, Kay AB. Menzies-Gow AN, et al. Among authors: robinson ds. Clin Exp Allergy. 2007 Jul;37(7):1023-32. doi: 10.1111/j.1365-2222.2007.02735.x. Clin Exp Allergy. 2007. PMID: 17581195 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,492 results

Search Page